{"id":"tp-48244","type":"article-newspaper","title":"Chemours Cuts High End of 2026 Adjusted EBITDA Forecast by $25 Million","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/48244","datePublished":"2026-11-04T05:04:15.000Z","dateModified":"2026-11-04T05:04:15.000Z","language":"en","abstract":"The company now expects about 2% sales growth and reduced its 2026 capital-spending range to $220 million to $230 million.","section":"Business","references":[]}